Found 13 results
Filters: Keyword is Prostate  [Clear All Filters]
2023
Subramanian K, Martinez J, Castellanos SHuicochea, Ivanidze J, Nagar H, Nicholson S, Youn T, Nauseef JT, Tagawa S, Osborne JR.  2023.  Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [18F]DCFPyL PET/CT in prostate cancer men.. Sci Rep. 13(1):8321.
Yun H, Kim J, Gandhe A, Nelson B, Hu JC, Gulani V, Margolis D, Schackman BR, Jalali A.  2023.  Cost-Effectiveness of Annual Prostate MRI and Potential MRI-Guided Biopsy After Prostate-Specific Antigen Test Results.. JAMA Netw Open. 6(11):e2344856.
Kang Z, Margolis DJ, Wang S, Li Q, Song J, Wang L.  2023.  Management Strategy for Prostate Imaging Reporting and Data System Category 3 Lesions.. Curr Urol Rep. 24(12):561-570.
Stangl-Kremser J, Sun M, Ho B, Thomas J, Nauseef JT, Osborne JR, Molina A, Sternberg CN, Nanus DM, Bander NH et al..  2023.  Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic castration-resistant prostate cancer receiving prostate-specific membrane antigen targeted radionuclide therapy.. Prostate. 83(14):1351-1357.
Kim H, Kang SWon, Kim J-H, Nagar H, Sabuncu M, Margolis DJA, Kim CKyo.  2023.  The role of AI in prostate MRI quality and interpretation: Opportunities and challenges.. Eur J Radiol. 165:110887.
Rogers HJ, Singh S, Barnes A, Obuchowski NA, Margolis DJ, Malyarenko DI, Chenevert TL, Shukla-Dave A, Boss MA, Punwani S.  2023.  Test-retest repeatability of ADC in prostate using the multi b-Value VERDICT acquisition.. Eur J Radiol. 162:110782.
Subramanian K, Stangl-Kremser J, Sawoszczyk L, Avlonitis V, Gernerd A, Nixon K, Zgaljardic M, Tagawa S, Bander N, Osborne JR.  2023.  α-Labeling of J591, an Antibody Targeting Prostate-Specific Membrane Antigen: The Technique and Considerations from the First Dedicated Production Lab at an Academic Institution in the United States.. J Nucl Med Technol. 51(3):215-219.